Pulmonary tuberculosis with false positive 18F-Fluorodeoxyglucose positron emission tomography mimicking recurrent lung cancer: A case report

Experimental and Therapeutic Medicine

Volumn 9, Issue 1, 2015, Pages 159-161

  Chen, Cheng ^a   Zhu, Ye Han ^a   Qian, Hong Ying ^a   Huang, Jian An ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Lung cancer; Positron emission tomography computed tomography; Recurrence; Tuberculosis

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; GEMCITABINE;

AGED; ARTICLE; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG TUBERCULOSIS; MALE; VIDEO ASSISTED THORACOSCOPIC SURGERY;

EID: 84919460762     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.2054     Document Type: Article

References (9)

1. Spiro SG, Gould MK and Colice GL; American College of Chest Physicians: Initial evaluation of the patient with lung cancer: Symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132 (3 Suppl): 149S-160S, 2007.
2. Liao S, Penney BC, Wroblewski K, et al: Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 39: 27-38, 2012.
3. Burdick MJ, Stephans KL, Reddy CA, Djemil T, Srinivas SM, and Videtic GM: Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 78: 1033-1039, 2010.
4. Li S, Zheng Q, Ma Y, Wang Y, Feng Y, Zhao B and Yang Y: Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of 18F-FDG PET/CT. PLoS One 8: e78552, 2013.
5. Suga K, Kawakami Y, Hiyama A, Sugi K, Okabe K, Matsumoto T, Ueda K, Tanaka N and Matsunaga N: Dual-time point 18F-FDG PET/CT scan for differentiation between 18F-FDG-avid non-small cell lung cancer and benign lesions. Ann Nucl Med 23: 427-435, 2009.
6. Fisher MD and D'Orazio A: Phase II and III trials: comparison of four chemotherapy regimens in advanced non small-cell lung cancer (ECOG 1594). Clin Lung Cancer 2: 21-22, 2000.
7. Tse LA, Mang OW, Yu IT, Wu F, Au JS and Law SC: Cigarette smoking and changing trends of lung cancer incidence by histological subtype among Chinese male population. Lung Cancer 66: 22-27, 2009.
8. Ozgül MA, Kirkil G, Seyhan EC, Cetinkaya E, Ozgül G and Yüksel M: The maximum standardized FDG uptake on PET-CT in patients with non-small cell lung cancer. Multidiscip Respir Med 8: 69, 2013.
9. Razak HR, Geso M, Abdul Rahim N and Nordin AJ: Imaging characteristics of extrapulmonary tuberculosis lesions on dual time point imaging (DTPI) of FDG PET/CT. J Med Imaging Radiat Oncol 55: 556-562, 2011.